The purpose of this study is to clarify the absorption characteristics of drugs across the serosal cecal surface membrane occupying a large absorption area in the peritoneal cavity in rats.
Introduction
The peritoneal cavity is a potential space for peritoneal dialysis as a long-term renal replacement therapy and intraperitoneal (i.p.) chemotherapy of cancer restricted to the peritoneal cavity e.g. ovarian carcinoma, and so on.
Although the i.p. route of drugs has attracted attention, it has not been clarified whether drug absorption from the peritoneal cavity occurs through specific organs. We previously examined the absorption characteristics of several compounds from the liver surface (Nishida et al 1994 (Nishida et al , 1995a (Nishida et al ,b, 1996 (Nishida et al , 1997 (Nishida et al , 2000 and serosal stomach surface Mukai et al 1999) in rats as a series of investigations.
Among the peritoneal organs in rats, the cecum is well developed and should play an important role in peritoneal drug transport because of its large surface area.
Although the surface area of the serosal cecum in the human peritoneal cavity is proportionally much smaller, the absorption mechanism from the serosal cecal surface needs to be examined to estimate the overall in-vivo absorption rate of a drug after i.p.
administration in human beings from the extrapolation of animal data such as rats.
In the present study, we investigated the absorption of an organic anion phenolsulphonphthalein as a model after application to the rat serosal cecal surface.
Furthermore, we selected three fluorescein isothiocyanate-dextrans with different molecular weights as model macromolecules to examine the molecular weight dependency.
Materials and Methods

Chemicals
Phenolsulphonphthalein (PSP) was purchased from Nacalai Tesque, Inc. (Kyoto, Japan).
Fluorescein isothiocyanate-dextrans (FDs) with average molecular weights of 4,400 (FD-4), 11,000 (FD-10), and 40,500 (FD-40) were obtained from Sigma Chemical Co. (St Louis, MO, USA). All other chemicals were of reagent grade.
In-vivo experiment
All animal experiments in the present study conformed to the Guideline for Animal Experimentation in Nagasaki University.
Male Wistar rats (250 -316 g) were housed in cages in an air-conditioned room and maintained on standard rat foods and water freely available. The left femoral artery and common bile duct of the rats previously anaesthetized with sodium pentobarbitone (50 mg kg -1 , i.p.) were cannulated with polyethylene tubes. A cylindrical diffusion cell (i.d. 6 mm, area 0.28 cm 2 ) was designed to fit over the rat serosal cecal membrane. Each compound was dissolved in 0.05 mL of isotonic phosphate buffer (pH 7.4) and added to the diffusion cell directly. After application to the rat serosal cecal surface, plasma, bile, urine and the remaining solution in the diffusion cell were sampled at the specified times.
Analytical methods
The concentrations of model compounds in the plasma, bile, urine and remaining solution in the diffusion cell were determined as follows. The concentration of free PSP was determined spectrophotometrically at 560 nm after dilution with 1 M NaOH.
The total concentration of free PSP and its metabolite was measured in the same manner after they were subjected to acid hydrolysis (2 M HCl at 100°C for 30 min) (Hart & Schanker 1966) . The concentration of PSP metabolite (glucuronic acid conjugate) was estimated from the difference between these values. The PSP metabolite could not be detected in the plasma.
The concentrations of FDs as fluorescence in the solution remaining in the diffusion cell were measured by a spectrophotofluorometer at excitation and emission wavelengths of 489 and 515 nm, respectively.
Calculation of moment parameters
The plasma concentration profiles and biliary excretion rate-time curves of free PSP and its metabolite were analyzed based on statistical moment theory. Moment parameters for plasma concentration profile of free PSP (AUC p , MRT p ) and those for biliary excretion rate-time curves of free PSP (AUC b,f , MRT b,f ) and its metabolite (AUC b,m , MRT b,m ) were calculated using a linear trapezoidal formula and extrapolation to infinite time based on a monoexponential equation (Yamaoka et al 1978) .
The overall absorption and excretion process can be evaluated with moment parameters.
In particular, AUC p and MRT p are useful parameters for roughly evaluating the drug absorbability from the peritoneal cavity with regard to extent and rate, respectively. Also, AUC b and MRT b are useful parameters for roughly evaluating the biliary excretion of drug with regard to extent and rate, respectively.
Statistical analysis
Statistical analysis was performed by applying unpaired Student's t-test. P < 0.05 was considered to be statistically significant. All values were expressed as the mean value ± standard error of at least four experiments.
Results and Discussion
We established the experimental system utilizing a cylindrical diffusion cell attached to the rat serosal cecal surface. This experimental system enables us to examine drug absorption from the serosal cecal surface without interference by absorption from other sites. We selected PSP as a low molecular weight model because their disposition characteristics have been investigated previously (Enna & Schanker 1973; Nishida et al 1989; Kakutani et al 1992) .
Plasma concentration and biliary excretion of PSP after application to the serosal cecal surface Figure 2A shows the plasma concentration profile of PSP after application to the rat serosal cecal surface at doses of 0.3, 0.5 and 1 mg. PSP appeared in the plasma, suggesting the occurrence of drug absorption from the rat serosal cecal surface. The plasma concentration of PSP after application to the rat serosal cecal surface reached a maximum about 1 h after dosing ( Fig. 2A) . After absorption from the rat serosal cecal surface, PSP was excreted into the bile as shown in Fig. 2B . The metabolite of PSP (glucuronic acid conjugate) was also excreted into the bile (Fig. 2C) . Therefore, PSP demonstrated fast absorption from the serosal cecal surface, although it is poorly absorbed from the gastrointestinal mucosa because it is highly ionized and has a very small partition coefficient at physiological pH (Shanker et al 1958) .
PSP absorbed from the serosal cecal surface tended to be excreted into the urine, compared with i.v. administration (Table 1) . The difference in the MRT p values between the serosal cecal surface application and i.v. administration corresponded to the mean time value for the absorption from the serosal cecal surface (MAT). MAT of PSP after application to the rat serosal cecal surface was calculated to be 75.8 min from the MRT p values listed in Table 2 .
Dose-dependency on PSP absorption from serosal cecal surface
As shown in Figs 2A, 2B and 2C, the shapes of plasma concentration profiles of free PSP and the biliary excretion rate-time curves of free PSP and its metabolite were almost identical among 0.3, 0.5 and 1 mg.
Recoveries (% of dose) of free PSP and its metabolite in the bile, urine and diffusion cell at doses of 0.3, 0.5 and 1 mg are given in Table 1 . Absorption ratios of PSP in 6 h calculated from the remaining amount of PSP in the diffusion cell were 85.7, 90.1 and 89.6%
at doses of 0.3, 0.5 and 1 mg, respectively, indicating that the PSP absorption from the rat serosal cecal surface shows no saturation within the dose range used. The decrease in the urinary recovery ratio of PSP metabolite could be responsible for the saturation of the metabolic process of PSP at a high dose. Moreover, the PSP renal clearance after application to the rat serosal cecal surface at a dose of 1 mg (0.384 mL min -1 ) was significantly declined (P < 0.05), compared to 0.3 mg (0.808 mL min -1 ). This suggests that the urinary secretion of PSP is also saturable.
Moment parameters for the plasma concentration profiles of free PSP and biliary excretion rate-time curves of free PSP and its metabolite are listed in Table 2 . No significant difference was seen in the AUC p /dose value among the three doses, suggesting the linearity of PSP absorption from the rat serosal cecal surface. Accordingly, a specific transport mechanism such as active transport might not be involved in PSP absorption from the rat serosal cecal surface, similar to other organ surfaces (Nishida et al 1995a; Mukai et al 1999) .
Time course of PSP amount in the diffusion cell after application to the serosal cecal surface
To assess the absorption characteristics from the rat serosal cecal surface, we studied the time course of the PSP amount in the diffusion cell (Fig. 3A) . A semi-log plot of the remaining PSP amount in the diffusion cell until 180 min gave a straight line (correlation coefficient: 0.94) as shown in Fig. 3A , indicating that the PSP absorption from the rat serosal cecal surface proceeds via first-order kinetics. Its first-order absorption rate constant K a was calculated to be 8.01 x 10 -3 min -1 .
Absorption of FDs with different molecular weights from the serosal cecal surface
Since there was a significant relation between the molecular weight and absorption rate constant after application of model compounds to the liver and serosal stomach surface (Nishida et al 1996; Mukai et al 1999) , the molecular weight appeared to play an important role in drug absorption from the serosal cecal surface.
We selected FDs as model macromolecules, and examined the molecular weight dependence of drug absorption from the serosal cecal surface in rats because dextrans are fairly resistant to metabolic degradation and their in-vivo fate has been characterized fully in rats (Nishida et al 1991; Mehvar & Shepard 1992; Mehvar et al 1994) . Figure 2B shows the time courses of FD-4 and FD-10 recovery in the diffusion cell until 180 min after application to the rat serosal cecal surface. This suggests that their absorption from the rat serosal cecal surface proceeds via first-order kinetics, similar to a small molecule PSP (Fig. 3A) . The K a values for FD-4 and FD-10 were calculated to be 1.62 x 10 -3 and 0.85 x 10 -3 min -1 , respectively. The absorption ratios from the rat serosal cecal surface in 3 h were calculated from the amount recovered from the diffusion cell, as 73.0% for PSP, 24.7% for FD-4, 12.8% for FD-10 and 3.4% for FD-40. Accordingly, comparison of the absorption of several model compounds with different molecular weights demonstrated that the absorption ratio decreased with the increase in the molecular weight.
Comparison of the absorption rates of PSP among the liver, stomach and cecal surface
We compared the absorption rate of PSP from the other previously investigated organ surfaces such as liver (Nishida et al 1995a) and stomach based on the clearance concept. The K a values of PSP from the other organ surfaces of liver (Nishida et al 1995a) and stomach have been obtained by the time courses of PSP recovery in the diffusion cell. We derived the apparent permeability coefficients (P app ) representing drug absorbability from the organ surface. P app was calculated by
where V a and Area mean the application volume and effective application area of the diffusion cell, respectively.
The P app values of PSP from the liver, stomach and cecal surface were calculated to be 10.9, 12.3 and 11.2 µm min -1 , respectively. No significant difference was seen in P app among the three organ surfaces, implying that these three organ surface membranes are broadly uniform with respect to absorption characteristics.
In conclusion, the absorption characteristics of the model compounds from the serosal cecal surface in rats would be useful to estimate the overall drug absorption rate after i.p.
administration. Each value is the mean ± s.e. of at least five experiments. S ignificantly different from 0.3 mg ( *** P < 0.001) and 0.5 mg ( § P < 0.05). 
